— · Drug Manufacturers - Specialty & Generic

Optimi Health Corp. (OPTH) Stock

$4.02 -1.59% —: OPTH Healthcare

Valuation

MetricValue
Price$4.02
Market Cap$12.95M
P/E Ratio-3.28
P/B Ratio1.56
P/S Ratio117.32
EPS (TTM)$-1.16
52-Week High$8.84
52-Week Low$4.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-84.23%
ROA-26.68%
ROCE-35.76%
Gross Margin-12.96%
Operating Margin-24.02%
Net Margin-20.70%
Debt/Equity0.29
Current Ratio0.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-6.0M$-7.0M$-4.0M$-6.0M$-5.0M
Net Profit$-6.0M$-7.0M$-5.0M$-6.0M$-4.0M
EPS$-0.12$-2.70$-1.79$-2.02$-1.16
Op Margin—-9155.2%-2419.1%-1438.8%-1062.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$23.0M$17.0M$16.0M$15.0M$15.0M
Total Liabilities$2.0M$1.0M$3.0M$5.0M$9.0M
Cash$8.0M$2.0M$1.0M$0$1.0M
Borrowings$0$0$2.0M$3.0M$7.0M

Latest News

3 Psychedelic Stocks With Potential Clinical Trial Catalysts Simply Wall St. · Jul 10, 2026 Weekly Roundup on the Cannabis Sector & Psychedelic Sector Market Exclusive · Jul 6, 2026 Optimi Health Makes Third Commercial Shipment of Psilocybin for Treatment-Resistant Depression to Australia MT Newswires · Jun 29, 2026 Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression PR Newswire · Jun 29, 2026 Optimi Health Completes Third Psilocybin Export to Australia MT Newswires · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-6.0M$-5.0M$-4.0M$-4.0M$-3.0M
Investing Cash Flow$-14.0M$-10.0M$-2.0M$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$4.0M$-7.0M$-1.0M$-1.0M$1.0M
Free Cash Flow$-11.0M$-12.0M$-4.0M$-4.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.07
EV / EBITDA-2.57
FCF Yield-25.76%
Quick Ratio1.69
Interest Coverage-6.42
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held0.60%
Institutions Held8.78%
Institutions Float Held8.83%
Institutional HolderSharesReport Date
AdvisorShares Trust-AdvisorShares Psychedelics ETF102,7942026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
MOOD.CNDoseology Sciences Inc. $0.12 -14.29% -1.12 $1.48M 0.00%
PSYC.CNPsyched Wellness Ltd. $0.01 +0.00% -0.50 $4.08M 0.00%

About Optimi Health Corp.

Optimi Health Corp. is led by CEO Dane Stevens, employs 6 people, headquartered in CA, publicly traded since 2026.

Optimi Health Corp. (OPTH) stock trades at $4.02 with a market capitalization of $12.95M. The stock is valued at a negative price-to-earnings (P/E) ratio of -3.28, reflecting a net loss over the last twelve months, price-to-book of 1.56, price-to-sales of 117.32. Over the past 52 weeks the stock has ranged between $4.00 and $8.84, and currently trades 54.5% below its 52-week high.

On profitability, Optimi Health Corp. generates a return on equity (ROE) of -84.23% (negative, reflecting a net loss), return on capital employed of -35.76%, an operating margin of -24.02%, a net profit margin of -20.70%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.